Analysis of the recent antipsychotic aripiprazole in human plasma by capillary electrophoresis and high-performance liquid chromatography with diode array detection

Analytica Chimica Acta

Volumn 612, Issue 2, 2008, Pages 204-211

  Musenga, Alessandro ^a   Saracino, Maria Addolorata ^a   Spinelli, Domenico ^a   Rizzato, Egon ^a   Boncompagni, Giancarlo ^b   Kenndler, Ernst ^c   Raggi, Maria Augusta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aripiprazole; Capillary electrophoresis; High performance liquid chromatography; Human plasma; Solid phase extraction; Therapeutic drug monitoring

Indexed keywords

DIODES; DRUG PRODUCTS; ELECTROLYTES; LIQUID CHROMATOGRAPHY; PLASMA (HUMAN);

ANTIPSYCHOTIC ARIPIPRAZOLE; DIODE ARRAY DETECTION; SCHIZOPHRENIC PATIENTS;

CAPILLARY ELECTROPHORESIS;

ACETONITRILE; ARIPIPRAZOLE; ELECTROLYTE; LOXAPINE; NEUROLEPTIC AGENT; PHOSPHATE BUFFERED SALINE; SILICON DIOXIDE; TRIETHYLAMINE;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DIODE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCHIZOPHRENIA; SOLID PHASE EXTRACTION; TABLET; VALIDATION PROCESS;

ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, CAPILLARY; HUMANS; MOLECULAR STRUCTURE; PIPERAZINES; QUINOLONES; REPRODUCIBILITY OF RESULTS;

EID: 40849097323     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2008.02.046     Document Type: Article

References (24)

1. Raggi M.A., Mandrioli R., Pucci V., and Sabbioni C. Med. Chem. Rev. Online 1 (2004) 299
2. Davies M.A., Sheffler D.J., and Roth B.L. CNS Drug Rev. 10 (2004) 317
3. Harrison T.S., and Perry C.M. Drugs 64 (2004) 1715
4. Green B. Curr. Med. Res. Opin. 20 (2004) 207
5. Stahl S.M. J. Clin. Psychiatry 62 (2001) 923
6. Marder S.R., McQuade R.D., Stock E., Kaplita S., Marcus R., Safferman A.Z., Saha A., Ali M., and Iwamoto T. Schizophr. Res. 61 (2003) 123
7. Newcomer J.W. CNS Drugs 19 (2005) 1
8. Raggi M.A., Mandrioli R., Sabbioni C., and Pucci V. Curr. Med. Chem. 11 (2004) 279
9. In: Sweetman S.C. (Ed). Martindale The Complete Drug Reference. 34th edition (2004), Pharmaceutical Press, London 671
10. Kumar M.V., and Muley P.R. Indian Pharmacist 4 (2005) 71
11. Ravindra N., and Singhvi I. Int. J. Chem. Sci. 4 (2006) 347
12. Shimokawa Y., Akiyama H., Kashiyama E., Koga T., and Miyamoto G. J. Chromatogr. B 821 (2005) 8
13. Molden E., Lunde H., Lunder N., and Refsum H. Ther. Drug Monit. 28 (2006) 744
14. Kubo M., Mizooku Y., Hirao Y., and Osumi T. J. Chromatogr. B 822 (2005) 294
15. Kirschbaum K.M., Mueller M.J., Zernig G., Saria A., Mobascher A., Malevani J., and Hiemke C. Clin. Chem. 51 (2005) 1718
16. Zuo X.C., Wang F., Xu P., Zhu R.H., and Li H.D. Chromatographia 64 (2006) 387
17. Kirchherr H., and Kuehn-Velten W.N. J. Chromatogr. B 843 (2006) 100
18. Huang H.C., Liu C.H., Lan T.H., Hu T.M., Chiu H.J., Wu Y.C., and Tseng Y.l. J. Chromatogr. B 856 (2007) 57
19. United States Pharmacopeia, 28th ed. United States Pharmacopeial Convention, Rockville (MD), 2005, p. 2748.
20. Shah V.P., Midha K.K., Findlay J.W.A., John W.A., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551
21. Oshiro Y., Sato S., Kurahashi N., Tanaka T., Kikuchi T., Tottori K., Uwahodo Y., and Nishi T. J. Med. Chem. 41 (1998) 658
22. Porras S.P., and Kenndler E. J. Chromatogr. A 1037 (2004) 455
23. Subirats X., Reinstadler S., Porras S.P., Raggi M.A., and Kenndler E. Electrophoresis 26 (2005) 3315
24. Raggi M.A., Bugamelli F., Sabbioni C., Saracino M.A., and Petio C. J. Sep. Sci. 28 (2005) 245